Zheng YJ

Institute of Medical Science, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada.

5 papers

ArticleKetamine

Cognitive effects of ketamine and esketamine treatment for major depressive and bipolar disorder: a systematic review.

Xiao K, Woo Y, Dri CE +12

Europe PMC2026
ArticleMDMA

The Serotonin 2B (5-HT2B) Receptor: A Narrative Review of Preclinical and Clinical Evidence on the Safety Considerations and Therapeutic Potential for the Treatment of Depression.

Le GH, Wong S, Johnson DE +6

Europe PMC2026
ArticleKetamine

Are the current safety measures for the treatment of depression with esketamine sufficient?

Valentino K, Teopiz KM, Dri CE +3

Europe PMC2026
ArticleKetamine

Effects of Intravenous Ketamine on Posttraumatic Stress Disorder (PTSD): A Systematic Review.

Yin L, Lu A, Le GH +13

Europe PMC2026
ArticleKetamine

The effects of ketamine and esketamine on functional outcomes in major depressive disorder and treatment-resistant depression: A systematic review.

Ji IS, Cheng MCH, Teopiz KM +8

Europe PMC2026